ResearcherGuiyang Medical UniversityActive in the last 2 years
Changhao Wu
Matched on ORCID iD 0009-0001-4294-4275; OpenAlex author ID A5101775058. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2023: 1 paper · 2024: none · 2025: 4 papers
Papers 5
- TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4. Co-author DOI 10.1016/j.drup.2024.101171↗
- ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer. Co-author DOI 10.1038/s41419-025-08061-6↗
- Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. Co-author DOI 10.1038/s41598-025-88265-0↗
- Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression. Co-author DOI 10.1186/s12935-025-03645-w↗
- FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis. Co-author DOI 10.1038/s41419-023-06207-y↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhiwei He · 5 shared papers, 2023–2025 · strength 1.30
- Paper TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent d… DOI 10.1016/j.drup.2024.101171↗
- Paper Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. DOI 10.1038/s41598-025-88265-0↗
- Paper Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression. DOI 10.1186/s12935-025-03645-w↗
- Dijie Zheng · 3 shared papers, 2025 · strength 0.81
- Paper TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent d… DOI 10.1016/j.drup.2024.101171↗
- Paper Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression. DOI 10.1186/s12935-025-03645-w↗
- Paper ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer. DOI 10.1038/s41419-025-08061-6↗
- Futang Li · 2 shared papers, 2025 · strength 0.54
- Paper TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent d… DOI 10.1016/j.drup.2024.101171↗
- Paper ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer. DOI 10.1038/s41419-025-08061-6↗
- Shiyu Chen · 2 shared papers, 2023–2025 · strength 0.49
- Paper Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. DOI 10.1038/s41598-025-88265-0↗
- Paper FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA… DOI 10.1038/s41419-023-06207-y↗
- Hao Hua · 2 shared papers, 2023–2025 · strength 0.47
- Chao Yu · 2 shared papers, 2023–2025 · strength 0.46
- Paper ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer. DOI 10.1038/s41419-025-08061-6↗
- Paper FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA… DOI 10.1038/s41419-023-06207-y↗
- Chengyi Sun · 1 shared paper, 2025 · strength 0.28
- Zhirui Zeng · 1 shared paper, 2025 · strength 0.28
- Chao Yu · 1 shared paper, 2025 · strength 0.28
- Chao Yu · 1 shared paper, 2025 · strength 0.28
- Chao Yuan Yu · 1 shared paper, 2025 · strength 0.27
- Yongning Li · 1 shared paper, 2025 · strength 0.26
- Cheng-Yi Sun · 1 shared paper, 2023 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.